Stability of extemporaneously compounded amiloride nasal spray
V. K. Yellepeddi, C. Sayre, A. Burrows, K. K. Watt, J. Strauss, S. Davies, M. Battaglia
Abstract
Anxiety disorders (AD) are the most common mental illnesses affecting an estimated 40 million adults in the United States. Amiloride, a diuretic agent, has shown efficacy in treating AD in preclinical models by inhibiting the acid-sensing ion channels (ASIC). By delivering amiloride via nasal route, rapid onset of action can be achieved due to direct "nose-to-brain" access. Therefore, this study reports the formulation, physical, chemical, and microbiological stability of an extemporaneously prepared amiloride 2 mg/mL nasal spray. The amiloride nasal spray was prepared by adding 100 mg of amiloride hydrochloride to 50 mL of sterile water for injection in a sterile reagent bottle. A stability-indicating high-performance liquid chromatography (HPLC) method was developed and validated. Forced-degradation studies were performed to confirm the ability of the HPLC method to identify the degradation products from amiloride distinctively. The physical stability of the amiloride nasal spray was assessed by pH, clarity, and viscosity assessments. For chemical stability studies, samples of nasal sprays stored at room temperature were collected at time-points 0, 3 hr., 24 hr., and 7 days and were assayed in triplicate using the stability-indicating HPLC method. Microbiological stability of the nasal spray solution was evaluated for up to 7 days based on the sterility test outlined in United States Pharmacopoeia (USP) chapter 71. The stability-indicting HPLC method identified the degradation products of amiloride without interference from amiloride. All tested solutions retained over 90% of the initial amiloride concentration for the 7-day study period. There were no changes in color, pH, and viscosity in any sample. The nasal spray solutions were sterile for up to 7 days in all samples tested. An extemporaneously prepared nasal spray solution of amiloride hydrochloride (2 mg/mL) was physically, chemically, and microbiologically stable for 7 days when stored at room temperature.
02 /Specification & Classification
Click any tag to browse matching papers- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Amorphous solid dispersions and the confounding effect of nanoparticles in in vitro dissolution and in vivo testing: Niclosamide as a case of study
M. O. Jara, Z. N. Warnken, R. O. Williams·PharmaceuticsPeer-reviewed·Jan 14, 2021
- Automated patch clamp screening of amiloride and 5-N,N-hexamethyleneamiloride (HMA) analogs identifies 6-iodoamiloride as a potent acid-sensing ion channel inhibitor.
R. K. Finol-Urdaneta, J. R. McArthur, … B. J. Buckley·bioRxiv·Mar 12, 2022
- Stability of Oxycodone Solutions Containing S-Ketamine or Dexmedetomidine
Patrik Vaisanen, Sanna Mäkelä, … Teijo I. Saari·European Journal of Hospital PharmacyPeer-reviewed·May 13, 2026
- The pH Dependence of Niclosamide Solubility, Dissolution, and Morphology Motivates Potentially Universal Mucin-Penetrating Nasal and Throat Sprays for COVID19, its Contagious Variants, and Other Respiratory Viral Infections
D. Needham·bioRxiv·Aug 16, 2021
- Formulation excipients and their role in insulin stability and association state in formulation
C. L. Maikawa, L. T. Nguyen, … E. A. Appel·bioRxiv·Aug 1, 2022
- Controlling swelling and release of hyaluronic acid during aqueous storage by in situ cross-linking during spray drying with alginate
D. Wong, J. C. Cunniffe, … T. Jeoh·bioRxiv·Jul 4, 2019